News | August 16, 2022
Kwality Pharmaceuticals Q1FY23 profit at Rs. 10.52 Cr
The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
Company appoints five new independent directors to reconstituted board
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
The company has reported total income of Rs. 403.38 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022.
The product will be manufactured at Lupin’s facility in Goa, India.
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
Subscribe To Our Newsletter & Stay Updated
